Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,640.1
-12.5 (-0.47%)

 

  • STI Straits Times Index
    2,640.1
    -12.5 (-0.47%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,603.3
    11.4 (0.72%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,727.4
    -
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,383.3
    -
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,627.1
    336.3 (1.51%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,031.3
    -
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 295.7M
  • Value: 185.3M
  • Rise: 121
  • Fall: 78
  • Unch: 609

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
MDR0.001-
Clearbridge0.200+0.015
Oceanus^0.007+0.001
Singapore-eDev0.129-0.001
Adventus0.026+0.001
Biolidics0.515+0.105
AsiaMedic0.031-
Medtecs Intl0.955+0.085
CSC0.020+0.001
Addvalue Tech0.028+0.001

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,265.5 -284.5
HSCEI 9,743.2 -110.0
Jakarta 4,863.1 -41.0
Nikkei 225 22,047.8 -464.2
SSE Comp 2,960.5 -10.1
Shanghai A 3,103.1 -10.6
Shanghai B 211.8 -1.7
KOSPI 2,097.3 -37.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

SERES THERAPEUTICS SERES THERAPEUTICS
Updated on 10 Jul 2020 (End of trading day)
Last (USD): 4.510 Change: -0.990 High: 5.540 Remarks: -
Change (%): -18.00 Low: 4.480
Open 5.500 Yesterday's Close 5.5
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 1,306,586 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.96804 Trailing EPS (USD) e -0.90672 NAV (USD) b -0.8492
PE a - Trailing PE f - Price / NAV b -5.3109
Dividend (USD) d - Cash In Hand (USD) g 0.7556 Issued & Paid-up Shares c 72,599,100
Dividend Yield (%) d - Price / Cash In Hand g 5.969 Treasury Shares h -
Market Cap (M) 327.422 Enterprise Value (M) 296.149
Piotroski F Score 1 Exchange Code MCRB Par Value ( $ ) n.a.
52 Weeks Volatility (%) 78.61 Free Float (%) 59.8
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 07 May 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 22 Jul 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference SERES THERAPEUTICS NASDAQ 327.422 - - -5.3109 -
Industry Biotechnology NASDAQ 2,964.263 370.178 6455.431 7.1605 0.643
Local Peer AMGEN INC NASDAQ 146,497.033 18.681 19.088 15.4451 2.341
Local Peer GILEAD SCIENCES INC NASDAQ 95,733.518 17.775 19.293 4.3383 3.333
Local Peer VERTEX PHARMACEUTICAL NASDAQ 76,344.113 64.874 50.528 11.8150 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 69,860.390 33.018 30.650 5.7579 -
Local Peer ILLUMINA INC NASDAQ 54,426.750 54.318 57.778 11.7426 -
Local Peer BIOGEN INC NASDAQ 45,509.591 7.729 7.741 3.6272 -
Local Peer SEATTLE GENETICS INC NASDAQ 30,180.334 - - 17.0933 -
Local Peer MODERNA INC NASDAQ 24,344.271 - - 14.8361 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 24,030.394 9.995 10.122 2.0455 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 22,796.312 - 199.957 7.0360 -
Local Peer INCYTE CORPORATION NASDAQ 22,771.995 50.955 - 11.7519 -
Local Peer ALNYLAM PHARMACEUTICALS INC NASDAQ 18,629.383 - - 13.8023 -
Other Local Peers BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), IMMUNOMEDICS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), NOVAVAX INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), BLUEBIRD BIO INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), FIBROGEN INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), TG THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), KODIAK SCIENCES INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), VIELA BIO INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), UNIQURE N.V. (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), ALECTOR INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), XENCOR INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), EPIZYME INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), CYTOKINETICS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), NANTKWEST INC (NASDAQ), VERACYTE INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), VAXCYTE INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), NKARTA INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), REGENXBIO INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), COMPUGEN (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), RETROPHIN INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), VBI VACCINES INC CDA (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), IMMATICS N V (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), MORPHIC HOLDING INC (NASDAQ), PRECIGEN INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), IMMUNOGEN INC (NASDAQ), OMEROS CORP (NASDAQ), AKOUOS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), GERON CORP (NASDAQ), AGENUS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), AVROBIO INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), VAXART INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), ARDELYX INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), ATHERSYS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), NEXTCURE INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), PERSONALIS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), PROTHENA CORP PLC (NASDAQ), XBIOTECH INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), MERUS B V (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), KAMADA (NASDAQ), IVERIC BIO INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), AFFIMED N V (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), MEDICINOVA INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), CHIASMA INC (NASDAQ), VERASTEM INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), XOMA CORP (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), CHIMERIX INC (NASDAQ), CONTRAFECT CORP (NASDAQ), AXCELLA HEALTH INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), IMV INC (NASDAQ), ARAVIVE INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), TREVENA INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), OTONOMY INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), INFLARX N V (NASDAQ), ORGENESIS INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), SAVARA INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), RECRO PHARMA INC (NASDAQ), RESTORBIO INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), SESEN BIO INC (NASDAQ), INMUNE BIO INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), VACCINEX INC (NASDAQ), SYNLOGIC INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), COHBAR INC (NASDAQ), CURIS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), EQUILLIUM INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), SOLIGENIX INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), BIONANO GENOMICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ADVAXIS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), BIOCARDIA INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), EVOGENE LTD (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), OCUGEN INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), PRECIPIO INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SENESTECH INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ)
Global Peer CSL ASX 128,209.816 47.787 44.259 14.8247 0.939
Global Peer AMGEN-T HKEx 588,247.000 9.574 9.804 8.0015 4.569
Global Peer AGILENT TECHNOLOGIES INC NYSE 27,610.839 25.780 40.426 5.7909 0.734
Global Peer WUXI BIO HKEx 199,048.949 173.150 173.151 13.9190 -
Global Peer SINO BIOPHARM HKEx 194,869.737 63.489 64.072 5.6244 0.514
Global Peer BEIGENE HKEx 115,090.140 - - 5.2800 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 4,940.272 90.648 72.544 4.5965 -
Global Peer 3SBIO HKEx 33,762.449 30.579 30.579 3.1359 -
Global Peer Lonza SGX 5,937.453 6.613 6.613 0.6568 4.787
Global Peer GENSCRIPT BIO HKEx 30,437.544 - - 10.2043 -
Other Global Peers HAOHAI BIOTEC (HKEx), VIVA BIOTECH (HKEx), ALPHAMAB-B (HKEx), MYOVANT SCIENCES LTD (NYSE), MESOBLAST LTD (ASX), ARCUS BIOSCIENCES INC (NYSE), FRONTAGE (HKEx), ASCENTAGE-B (HKEx), POLYNOVO LIMITED (ASX), KINTOR PHARMA-B (HKEx), KADMON HLDGS INC (NYSE), SINOMAB BIO-B (HKEx), ASCLETIS-B (HKEx), NANOVIRICIDES INC (NYSE American), LEE'S PHARM (HKEx), ESSEX BIO-TECH (HKEx), TELIX PHARMACEUTIC (ASX), DPHARMA (Bursa), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), IBIO INC (NYSE American), PFENEX INC (NYSE American), NEXT SCIENCE LTD (ASX), ENZO BIOCHEM INC (NYSE), CEL-SCI CORP (NYSE American), LINEAGE CELL THERAPEUTICS INC (NYSE American), UNI-BIO GROUP (HKEx), NEUREN PHARMACEUTICALS LTD (ASX), IMUGENE LIMITED (ASX), AIM IMMUNOTECH INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), SYNTHETIC BIOLOGICS INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), INVEX THERAPEUTICS LTD NPV (ASX), IMMUTEP LTD (ASX), BIOTRON (ASX), ORAGENICS INC (NYSE American), CYNATA THERAPEUTICS LTD (ASX), CT ENTERPRISE (HKEx), MEMPHASYS LTD (ASX), KAZIA THERAPEUTICS LIMITED (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), BIOSINO BIO-TEC (HKEx), GENETIC TECHNOLOGIES (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), BIONOMICS LTD (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), ANTEOTECH LIMITED (ASX), Suntar Eco-City (SGX), REGENT PACIFIC (HKEx), ACTINOGEN MEDICAL LTD (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), SIENNA CANCER DIAGNOSTICS LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), PRESCIENT THERAPEUTICS LIMITED (ASX), REGENEUS LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), RHINOMED LIMITED (ASX), PATRYS LIMITED (ASX), ADALTA LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), CRYOSITE (ASX), LEAF RESOURCES LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), NANOLLOSE LTD (ASX), HAO WEN HLDGS (HKEx)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.480
-9.62 %
10 Days --0.240
-5.05 %
20 Days -+0.130
+2.97 %
Medium Term Return 3 Months -+1.120
+33.04 %
6 Months -+1.640
+57.14 %
1 Year -+1.620
+56.06 %
Long Term Return 2 Years --4.240
-48.46 %
3 Years --6.750
-59.95 %
5 Years --39.480
-89.75 %
Annualised Return Annualised --
-36.59 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 2.150 - 6.750 Change From 1 Year Low +2.360 % Change From 1 Year Low (%) +109.77
Change From 1 Year High -2.240 % Change From 1 Year High (%) -33.19
2 Years Range 2.020 - 9.260 Change From 2 Years Low +2.490 % Change From 2 Years Low (%) +123.27
Change From 2 Years High -4.750 % Change From 2 Years High (%) -51.30
5 Years Range 2.020 - 52.000 Change From 5 Years Low +2.490 % Change From 5 Years Low (%) +123.27
Change From 5 Years High -47.490 % Change From 5 Years High (%) -91.33
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.

Historical Price Data

Date Open High Low Close Volume VWAP
10 Jul 2020 5.500 5.540 4.480 4.510 1,306,586 -
09 Jul 2020 5.940 6.189 5.450 5.500 879,414 -
08 Jul 2020 5.750 6.750 5.610 5.900 1,446,979 -
07 Jul 2020 5.080 5.720 5.064 5.640 1,818,512 -
06 Jul 2020 5.130 5.520 5.010 5.090 1,168,703 -
02 Jul 2020 4.920 5.230 4.770 4.990 752,264 -
01 Jul 2020 4.800 4.900 4.655 4.800 555,694 -
30 Jun 2020 4.800 5.280 4.620 4.760 840,033 -
29 Jun 2020 4.720 4.950 4.580 4.670 472,570 -
26 Jun 2020 4.920 4.995 4.630 4.750 1,680,508 -
25 Jun 2020 4.760 5.090 4.690 4.920 363,021 -
24 Jun 2020 4.940 5.141 4.580 4.730 444,481 -
23 Jun 2020 4.940 5.120 4.920 4.990 444,068 -
22 Jun 2020 4.810 5.020 4.620 4.860 550,362 -
19 Jun 2020 4.470 5.351 4.430 4.800 2,230,702 -
18 Jun 2020 4.690 4.880 4.280 4.400 1,048,148 -
17 Jun 2020 4.700 4.890 4.610 4.720 210,281 -
16 Jun 2020 4.650 4.950 4.545 4.700 438,972 -
15 Jun 2020 4.350 4.670 4.120 4.570 350,555 -
12 Jun 2020 4.570 4.680 4.160 4.380 374,557 -
11 Jun 2020 4.470 4.560 4.370 4.440 404,774 -
10 Jun 2020 4.660 4.780 4.500 4.660 261,884 -
Summary
Current 2 Weeks
(26 Jun 2020 to 10 Jul 2020)
4.920 6.750 4.480 4.510 10,921,263 -
Previous 2 Weeks
(12 Jun 2020 to 25 Jun 2020)
4.570 6.750 4.160 4.920 6,455,147 -
4 Weeks from
(14 May 2020 to 11 Jun 2020)
4.580 6.750 4.340 4.440 8,749,382 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.